Developing mRNA for therapy
For four decades, my research has been focusing on RNA-mediated mechanisms with the ultimate goal of developing in vitro-transcribed mRNA for protein therapy. I investigated RNA-mediated immune activation and co-discovered that nucleoside modifications suppress immunogenicity of RNA, which widened the therapeutic potentials of mRNA.
Keywords
RNA modification / mRNA vaccine development / COVID-19 / personalized therapeutics / cancer